Advertisement

Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 391, Issue 3, pp 271–283 | Cite as

Apigenin reduces the Toll-like receptor-4-dependent activation of NF-κB by suppressing the Akt, mTOR, JNK, and p38-MAPK

Original Article
  • 180 Downloads

Abstract

Flavone apigenin has an anti-inflammatory effect. We assessed whether apigenin may reduce the inflammatory mediator production, which is regulated by the Toll-like receptor-4-dependent activation of the Akt, mTOR, and NF-κB pathways, and activation of JNK and p38-MAPK in HEK001 keratinocytes and primary keratinocytes. Apigenin, the Akt inhibitor, Bay 11-7085, and N-acetylcysteine inhibited the lipopolysaccharide-stimulated production of cytokines IL-1β and IL-6 and chemokines CCL17 and CCL27; the expression of cyclooxygenase-2; the increase in the levels of Toll-like receptor-4, phosphorylated Akt, and mTOR; the activation of NF-κB; the activation of the JNK and p38-MAPK; and the production of reactive oxygen/nitrogen species in keratinocytes. Inhibitors of the c-JNK (SP600125) and p38-MAPK (SB203580) reduced lipopolysaccharide-induced production of inflammatory mediators and activation of the JNK and p38-MAPK in keratinocytes. These results show that apigenin may inhibit the lipopolysaccharide-caused inflammatory mediator production in keratinocytes by reducing the Toll-like receptor-4-dependent activation of Akt, mTOR, and NF-κB pathways, and activation of JNK and p38-MAPK. The suppressive effect of apigenin may be achieved by the inhibition of reactive oxygen/nitrogen species production. Additionally, apigenin appears to reduce the Akt, mTOR, and NF-κB pathway- and the JNK and p38-MAPK-mediated inflammatory skin diseases.

Keywords

Keratinocytes Lipopolysaccharide Apocynin Toll-like receptor-4 Akt, mTOR, and NF-κB pathways JNK and p38-MAPK Inflammatory mediator production 

References

  1. Baker BS (2006) The role of microorganisms in atopic dermatitis. Clin Exp Immunol 144(1):1–9.  https://doi.org/10.1111/j.1365-2249.2005.02980.x CrossRefPubMedPubMedCentralGoogle Scholar
  2. Begon E, Michel L, Flageul B, Beaudoil I, Jean-Louis F, Bachelez H, Dubertret L, Musette P (2007) Expression, subcellular localization and cytokinic modulation of Toll-like receptors (TLRs) in normal human keratinocytes: TLR2 up-regulation in psoriatic skin. Eur J Dermatol 17(6):497–506.  https://doi.org/10.1684/ejd.2007.0264 PubMedGoogle Scholar
  3. Bi C, Jiang Y, Fu T, Hao Y, Zhu X, Lu Y (2016) Naringin inhibits lipopolysaccharide-induced damage in human umbilical vein endothelial cells via attenuation of inflammation, apoptosis and MAPK pathways. Cytotechnology 68(4):1473–1487.  https://doi.org/10.1007/s10616-015-9908-3 CrossRefPubMedPubMedCentralGoogle Scholar
  4. Crespo I, García-Mediavilla MV, Almar M, González P, Tuñón MJ, Sánchez-Campos S, González-Gallego J (2008) Differential effects of dietary flavonoids on reactive oxygen and nitrogen species generation and changes in antioxidant enzyme expression induced by proinflammatory cytokines in Chang liver cells. Food Chem Toxicol 46(5):1555–1569.  https://doi.org/10.1016/j.fct.2007.12.014 CrossRefPubMedGoogle Scholar
  5. Farkas O, Palócz O, Pászti-Gere E, Gálfi P (2015) Polymethoxyflavone apigenin-trimethylether suppresses LPS-induced inflammatory response in nontransformed porcine intestinal cell line IPEC-J2. Oxidative Med Cell Longev 2015:1–10.  https://doi.org/​10.1155/2015/673847
  6. Fu W, Luo H, Parthasarathy S, Mattson MP (1998) Catecholamines potentiate amyloid β-peptide neurotoxicity: involvement of oxidative stress, mitochondrial dysfunction, and perturbed calcium homeostasis. Neurobiol Dis 5(4):229–243.  https://doi.org/10.1006/nbdi.1998.0192 CrossRefPubMedGoogle Scholar
  7. Ge Y, Xu Y, Sun W, Man Z, Zhu L, Xia X, Zhao L, Zhao Y, Wang X (2012) The molecular mechanisms of the effect of dexamethasone and cyclosporin A on TLR4/NF-κB signaling pathway activation in oral lichen planus. Gene 508(2):157–164.  https://doi.org/10.1016/j.gene.2012.07.045 CrossRefPubMedGoogle Scholar
  8. Ghosh S, Hayden MS (2008) New regulators of NF-κB in inflammation. Nat Rev Immunol 8(11):837–848.  https://doi.org/10.1038/nri2423 CrossRefPubMedGoogle Scholar
  9. Gloire G, Legrand-Poels S, Piette J (2006) NF-κB activation by reactive oxygen species: fifteen years later. Biochem Pharmacol 72(11):1493–1505.  https://doi.org/10.1016/j.bcp.2006.04.011 CrossRefPubMedGoogle Scholar
  10. Hsu HY, Wen MH (2002) Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression. J Biol Chem 277(25):22131–22139.  https://doi.org/10.1074/jbc.M111883200 CrossRefPubMedGoogle Scholar
  11. Huang CH, Kuo PL, Hsu YL, Chang TT, Tseng HI, Chu YT, Kuo CH, Chen HN, Hung CH (2010) The natural flavonoid apigenin suppresses Th1- and Th2-related chemokine production by human monocyte THP-1 cells through mitogen-activated protein kinase pathways. J Med Food 13(2):391–398.  https://doi.org/10.1089/jmf.2009.1229 CrossRefPubMedGoogle Scholar
  12. Jin SE, Lim HS, Kim Y, Seo CS, Yoo SR, Shin HK, Jeong SJ (2015) Traditional herbal formula banhasasim-tang exerts anti-inflammatory effects in RAW 264.7 macrophages and HaCaT keratinocytes. Evid Based Complement Alternat Med 2015:728380PubMedPubMedCentralGoogle Scholar
  13. Kim EK, Choi EJ (2015) Compromised MAPK signaling in human diseases: an update. Arch Toxicol 89(6):867–882.  https://doi.org/10.1007/s00204-015-1472-2 CrossRefPubMedGoogle Scholar
  14. Kim JE, Kim BJ, Jeong MS, Seo SJ, Kim MN, Hong CK, Ro BI (2005) Expression and modulation of LL-37 in normal human keratinocytes, HaCaT cells and inflammatory skin diseases. J Korean Med Sci 20(4):649–654.  https://doi.org/10.3346/jkms.2005.20.4.649 CrossRefPubMedPubMedCentralGoogle Scholar
  15. Kim AR, Lee B, Joung EJ, Gwon WG, Utsuki T, Kim NG, Kim HR (2016) 6,6′-Bieckol suppresses inflammatory responses by down-regulating nuclear factor-κB activation via Akt, JNK, and p38 MAPK in LPS-stimulated microglial cells. Immunopharmacol Immunotoxicol 38(3):244–252.  https://doi.org/10.3109/08923973.2016.1173060 CrossRefPubMedGoogle Scholar
  16. Korbecki J, Baranowska-Bosiacka I, Gutowska I, Chlubek D (2013) The effect of reactive oxygen species on the synthesis of prostanoids from arachidonic acid. J Physiol Pharmacol 64(4):409–421PubMedGoogle Scholar
  17. Lee AK, Sung SH, Kim YC, Kim SG (2003) Inhibition of lipopolysaccharide-inducible nitric oxide synthase, TNF-α and COX-2 expression by sauchinone effects on I-κBα phosphorylation, C/EBP and AP-1 activation. Br J Pharmacol 139(1):11–20.  https://doi.org/10.1038/sj.bjp.0705231 CrossRefPubMedPubMedCentralGoogle Scholar
  18. Lee SA, Park SH, Kim BC (2008) Raloxifene, a selective estrogen receptor modulator, inhibits lipopolysaccharide-induced nitric oxide production by inhibiting the phosphatidylinositol 3-kinase/Akt/NF-κB pathway in RAW264.7 macrophage cells. Mol Cells 26(1):48–52PubMedGoogle Scholar
  19. Lee CS, Jang ER, Kim YJ, Lee MS, Seo SJ, Lee MW (2010) Hirsutenone inhibits lipopolysaccharide-activated NF-κB-induced inflammatory mediator production by suppressing Toll-like receptor 4 and ERK activation. Int Immunopharmacol 10(4):520–525.  https://doi.org/10.1016/j.intimp.2010.01.015 CrossRefPubMedGoogle Scholar
  20. Lim R, Barker G, Wall CA, Lappas M (2013) Dietary phytophenols curcumin, naringenin and apigenin reduce infection-induced inflammatory and contractile pathways in human placenta, foetal membranes and myometrium. Mol Hum Reprod 19(7):451–462.  https://doi.org/10.1093/molehr/gat015 CrossRefPubMedGoogle Scholar
  21. Liu SY, Xu P, Luo XL, Hu JF, Liu XH (2016) (7R,8S)-dehydrodiconiferyl alcohol suppresses lipopolysaccharide-induced inflammatory responses in BV2 microglia by inhibiting MAPK signaling. Neurochem Res 23:541–549Google Scholar
  22. Ma C, Zhu L, Wang J, He H, Chang X, Gao J, Shumin W, Yan T (2015) Anti-inflammatory effects of water extract of Taraxacum mongolicum hand.-Mazz on lipopolysaccharide-induced inflammation in acute lung injury by suppressing PI3K/Akt/mTOR signaling pathway. J Ethnopharmacol 168:349–355.  https://doi.org/10.1016/j.jep.2015.03.068 CrossRefPubMedGoogle Scholar
  23. Morris MC, Gilliam EA, Li L (2015) Innate immune programing by endotoxin and its pathological consequences. Front Immunol 5:680CrossRefPubMedPubMedCentralGoogle Scholar
  24. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65(1–2):55–63.  https://doi.org/10.1016/0022-1759(83)90303-4 CrossRefPubMedGoogle Scholar
  25. Napetschnig J, Wu H (2013) Molecular basis of NF-κB signaling. Annu Rev Biophys 42(1):443–468.  https://doi.org/10.1146/annurev-biophys-083012-130338 CrossRefPubMedPubMedCentralGoogle Scholar
  26. Nicholas C, Batra S, Vargo MA, Voss OH, Gavrilin MA, Wewers MD, Guttridge DC, Grotewold E, Doseff AI (2007) Apigenin blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-kappaB through the suppression of p65 phosphorylation. J Immunol 179(10):7121–7127.  https://doi.org/10.4049/jimmunol.179.10.7121 CrossRefPubMedGoogle Scholar
  27. Park JY, Kim SI, Lee HJ, Kim SS, Kwon YS, Chun W (2016) Isorhamnetin-3-O-glucuronide suppresses JNK and p38 activation and increases heme-oxygenase-1 in lipopolysaccharide-challenged RAW264.7 cells. Drug Dev Res 77(3):143–151.  https://doi.org/10.1002/ddr.21301 CrossRefPubMedGoogle Scholar
  28. Pastore S, Mascia F, Girolomoni G (2006) The contribution of keratinocytes to the pathogenesis of atopic dermatitis. Eur J Dermatol 16:125–113PubMedGoogle Scholar
  29. Patil RH, Babu RL, Naveen Kumar M, Kiran Kumar KM, Hegde SM, Nagesh R, Ramesh GT, Sharma SC (2016) Anti-inflammatory effect of apigenin on LPS-induced pro-inflammatory mediators and AP-1 factors in human lung epithelial cells. Inflammation 39(1):138–147.  https://doi.org/10.1007/s10753-015-0232-z CrossRefPubMedGoogle Scholar
  30. Pumklin J, Bhalang K, Pavasant P (2016) Hypoxia enhances the effect of lipopolysaccharide-stimulated IL-1β expression in human periodontal ligament cells. Odontology 104(3):338–346.  https://doi.org/10.1007/s10266-015-0223-4 CrossRefPubMedGoogle Scholar
  31. Schaerli P, Moser B (2005) Chemokines: control of primary and memory T-cell traffic. Immunol Res 31(1):57–74.  https://doi.org/10.1385/IR:31:1:57 CrossRefPubMedGoogle Scholar
  32. Schreiber E, Matthias P, Müller MM, Schaffner W (1989) Rapid detection of octamer binding proteins with ‘mini-extracts’, prepared from a small number of cells. Nucleic Acids Res 17(15):6419.  https://doi.org/10.1093/nar/17.15.6419 CrossRefPubMedPubMedCentralGoogle Scholar
  33. Sharma JN, Al-Omran A, Parvathy SS (2007) Role of nitric oxide in inflammatory diseases. Inflammopharmacology 6:252–259CrossRefGoogle Scholar
  34. Siomek A (2012) NF-κB signaling pathway and free radical impact. Acta Biochim Pol 59(3):323–331PubMedGoogle Scholar
  35. Song PI, Park YM, Abraham T, Harten B, Zivony A, Neparidze N, Armstrong CA, Ansel JC (2002) Human keratinocytes express functional CD14 and toll-like receptor 4. J Investig Dermatol 119(2):424–432.  https://doi.org/10.1046/j.1523-1747.2002.01847.x CrossRefPubMedGoogle Scholar
  36. Sun XF, Zhang H (2007) NFκB and NFκBI polymorphisms in relation to susceptibility of tumour and other diseases. Histol Histopathol 22(12):1387–1398.  https://doi.org/10.14670/HH-22.1387 PubMedGoogle Scholar
  37. Takeda K, Akira S (2005) Toll-like receptors in innate immunity. Int Immunol 17(1):1–14.  https://doi.org/10.1093/intimm/dxh186 CrossRefPubMedGoogle Scholar
  38. Thomson AW, Turnquist HR, Raimondi G (2009) Immunoregulatory functions of mTOR inhibition. Nat Rev Immunol 9(5):324–337.  https://doi.org/10.1038/nri2546 CrossRefPubMedPubMedCentralGoogle Scholar
  39. Vane JR, Botting RM (1998) Anti-inflammatory drugs and their mechanism of action. Inflamm Res 47:S78–S87CrossRefPubMedGoogle Scholar
  40. Wang J, Liao Y, Fan J, Ye T, Sun X, Dong S (2012) Apigenin inhibits the expression of IL-6, IL-8, and ICAM-1 in DEHP-stimulated human umbilical vein endothelial cells and in vivo. Inflammation 35(4):1466–1476.  https://doi.org/10.1007/s10753-012-9460-7 CrossRefPubMedGoogle Scholar
  41. Wang J, Liu YT, Xiao L, Zhu L, Wang Q, Yan T (2014) Anti-inflammatory effects of apigenin in lipopolysaccharide-induced inflammatory in acute lung injury by suppressing COX-2 and NF-κB pathway. Inflammation 37(6):2085–2090.  https://doi.org/10.1007/s10753-014-9942-x CrossRefPubMedGoogle Scholar
  42. Wu H, Zhao G, Jiang K, Chen X, Zhu Z, Qiu C, Li C, Deng G (2016) Plantamajoside ameliorates lipopolysaccharide-induced acute lung injury via suppressing NF-κB and MAPK activation. Int Immunopharmacol 35:315–322.  https://doi.org/10.1016/j.intimp.2016.04.013 CrossRefPubMedGoogle Scholar
  43. Zhong LM, Zong Y, Sun L, Guo JZ, Zhang W, He Y, Song R, Wang WM, Xiao CJ, Lu D (2012) Resveratrol inhibits inflammatory responses via the mammalian target of rapamycin signaling pathway in cultured LPS-stimulated microglial cells. PLoS One 7(2):e32195.  https://doi.org/10.1371/journal.pone.0032195 CrossRefPubMedPubMedCentralGoogle Scholar
  44. Zhu W, Li J, Liu Y, Xie K, Wang L, Fang J (2016) Mesencephalic astrocyte-derived neurotrophic factor attenuates inflammatory responses in lipopolysaccharide-induced neural stem cells by regulating NF-κB and phosphorylation of p38-MAPKs pathways. Immunopharmacol Immunotoxicol 38(3):205–213.  https://doi.org/10.3109/08923973.2016.1168433 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2017

Authors and Affiliations

  1. 1.Department of Pharmacology, College of MedicineChung-Ang UniversitySeoulSouth Korea
  2. 2.The BK21plus Skin Barrier Network Human Resources Development TeamChung-Ang UniversitySeoulSouth Korea

Personalised recommendations